What is Biosyntia?
Founded in 2012 by Hans Genee, Andreas Lausten, and Professor Morten Sommer, Biosyntia specializes in industrial biotech, developing bio-based manufacturing processes with core capabilities in strain engineering and fermentation. The company leverages its Biosynthetic Selections technology to accelerate the development of microbial strains and fermentation processes, aiming to drastically reduce the risk, cost, and time associated with bringing new bio-based products to market. Biosyntia's innovative approach has garnered significant recognition, including being named one of Europe's most innovative SMEs.
How much funding has Biosyntia raised?
Biosyntia has raised a total of $13.6M across 2 funding rounds:
Angel/Seed
$1.9M
Other Financing Round
$11.7M
Angel/Seed (2015): $1.9M with participation from Novo A/S
Other Financing Round (2022): $11.7M led by Sofinnova Partners, European Circular Bioeconomy Fund, and Novo Seeds
Key Investors in Biosyntia
Novo A/S
Novo Holdings is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, focusing on investments within the life sciences.
European Circular Bioeconomy Fund
The European Circular Bioeconomy Fund (ECBF) is a specialist venture capital firm dedicated to investing in pioneering companies within the regenerative economy, aiming to drive economic growth while prioritizing environmental sustainability.
Novo Seeds
Novo Seeds is an investment entity focused on early-stage companies within the life sciences sector, providing crucial seed capital to foster innovation and growth.
What's next for Biosyntia?
With the recent major strategic investment, Biosyntia is poised to further scale its operations and accelerate the commercialization of its bio-manufacturing solutions. The company's focus on efficiency and speed in process development positions it to capitalize on the growing demand for sustainable, bio-based alternatives across various industries. This latest round of financing will likely support expanded research and development, enhance production capabilities, and strengthen market penetration, solidifying Biosyntia's role in the evolving bioeconomy.
See full Biosyntia company page
